tiprankstipranks
Advertisement

EFG - ETF AI Analysis

Compare

Top Page

EFG

iShares MSCI EAFE Growth ETF (EFG)

Rating:65Neutral
Price Target:
EFG, the iShares MSCI EAFE Growth ETF, has a solid overall rating driven mainly by high-quality growth companies like ASML, AstraZeneca, Novartis, ABB, and Hitachi, all showing strong financial performance, positive outlooks, and generally supportive technical trends. Some holdings such as SAP and Schneider Electric contribute less due to bearish technical signals and concerns about rich valuations, and several top names across the fund appear somewhat expensive, making valuation risk and growth-stock concentration the main factors that may hold the rating back.
Positive Factors
Strong Recent Short-Term Performance
The ETF has shown strong gains over the past month and a positive return so far this year, indicating solid recent momentum.
Leading Growth Companies in Top Holdings
Several of the largest positions, such as ASML, ABB, and Siemens Energy, have delivered strong year-to-date performance, helping drive the fund’s returns.
Broad International Diversification
Holdings spread across many developed markets like Japan, the UK, France, Germany, and others help reduce reliance on any single country’s economy.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low for a passive ETF, which slightly reduces the net return investors keep over time.
Exposure to Some Weak Top Holdings
A few major positions, including SAP, LVMH, and Hitachi, have shown weak year-to-date performance, which can drag on overall results if the trend continues.
Limited U.S. Market Exposure
With only a small portion of assets in U.S. stocks, the ETF may lag global benchmarks during periods when the U.S. market outperforms other regions.

EFG vs. SPDR S&P 500 ETF (SPY)

EFG Summary

The iShares MSCI EAFE Growth ETF (EFG) is a fund that follows the MSCI EAFE Growth Index, focusing on fast-growing companies in developed markets outside the U.S. and Canada, such as Japan, the UK, and Europe. It holds well-known international names like ASML Holding and AstraZeneca, giving you broad exposure to many industries, including technology, health care, and industrials. An investor might choose EFG to seek long-term growth while diversifying beyond the U.S. stock market. A key risk is that growth stocks and foreign markets can be more volatile, so the share price can rise and fall significantly over time.
How much will it cost me?The iShares MSCI EAFE Growth ETF (EFG) has an expense ratio of 0.36%, meaning you’ll pay $3.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a growth-focused index, which requires more active management compared to broad, passively managed funds. It’s still considered reasonable for the specialized exposure it provides.
What would affect this ETF?The iShares MSCI EAFE Growth ETF could benefit from continued innovation and expansion in technology and industrial sectors, which make up a significant portion of its holdings. However, challenges like rising interest rates or economic slowdowns in developed markets outside North America could negatively impact growth-focused companies. Additionally, regulatory changes or geopolitical tensions in regions like Europe or Asia may affect the ETF’s performance.

EFG Top 10 Holdings

EFG’s story is being written largely by its international tech and industrial champions. ASML and Tokyo Electron are powering ahead, giving the fund a strong tailwind from the semiconductor boom, while ABB and Siemens Energy add extra lift from the industrial side with rising share prices. On the flip side, SAP has been losing steam and AstraZeneca has been lagging, softening some of those gains. Overall, the ETF leans toward growth-heavy tech and industrial names across Europe and Japan, with no U.S. exposure, making it a pure developed-markets ex-North America play.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV5.69%$868.08M€538.22B118.64%
76
Outperform
AstraZeneca2.79%$425.90M$290.06B33.35%
80
Outperform
Novartis AG2.73%$416.29MCHF218.09B28.78%
80
Outperform
SAP SE1.68%$256.38M€177.21B-41.68%
66
Neutral
Schneider Electric1.68%$255.60M€151.54B23.19%
62
Neutral
ABB Ltd1.60%$243.46MCHF150.87B77.24%
78
Outperform
Siemens Energy1.50%$228.61M€149.44B115.01%
72
Outperform
1.46%$223.34M
Tokyo Electron1.41%$215.31M¥22.65T107.30%
73
Outperform
Hitachi,Ltd.1.38%$210.78M¥22.62T18.91%
77
Outperform

EFG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
116.99
Positive
100DMA
118.07
Positive
200DMA
115.09
Positive
Market Momentum
MACD
0.71
Positive
RSI
55.61
Neutral
STOCH
76.60
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 119.83, equal to the 50-day MA of 116.99, and equal to the 200-day MA of 115.09, indicating a bullish trend. The MACD of 0.71 indicates Positive momentum. The RSI at 55.61 is Neutral, neither overbought nor oversold. The STOCH value of 76.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFG.

EFG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$15.50B0.36%
65
Neutral
$184.72B0.07%
65
Neutral
$76.75B0.32%
66
Neutral
$30.46B0.33%
67
Neutral
$11.56B0.20%
65
Neutral
$10.70B0.24%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EFG
iShares MSCI EAFE Growth ETF
122.94
15.18
14.09%
IEFA
iShares Core MSCI EAFE ETF
EFA
iShares MSCI EAFE ETF
EFV
iShares MSCI EAFE Value ETF
ESGD
iShares ESG Aware MSCI EAFE ETF
JIRE
JPMorgan International Research Enhanced Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement